| Variables |
PPCABG (n=492) |
NVCABG (n=1866) |
P-values |
| Male gender |
366(74.4%) |
1398(74.9%) |
ns |
| Age (years) |
58.6(±9.4) |
56.7(±10.7) |
ns |
| Height |
163.6(±20) |
161.2(±15.7) |
ns |
| Weight |
84(±21.3) |
76(±15.4) |
ns |
| Body surface area |
1.83 (± 2.3) |
1.81(±2.0) |
ns |
| Urgent Presentation |
156(31.7%) |
126(6.8%) |
<0.05* |
| Recent MI |
270(54.91%) |
1302(69.8%) |
ns |
| Diabetes |
402(81.7%) |
1344(72.0%) |
ns |
| Hypertension |
408(82.9%) |
1332(71.4%) |
ns |
| Smoking |
246(50.0%) |
1044(55.9%) |
ns |
| Positive family history |
120(24.4%) |
480(25.7%) |
ns |
| Dyslipidemia |
438(89.0%) |
1350(72.3%) |
ns |
| Clopidogril use |
348(70.7%) |
0(0%) |
<0.05* |
| Statin use |
460(93.5%) |
618(33.2%) |
<0.05* |
| NYHA class |
| No SOB |
78(15.9%) |
12(0.6%) |
<0.05* |
| I |
120(24.4%) |
834(44.7%) |
|
| II |
192(39%) |
576(30.9%) |
|
| III |
84(17%) |
354(19%) |
|
| IV |
18(3.7%) |
90(4.8%) |
ns |
| EF |
45.2(10.6±) |
47.1(9.3±) |
ns |
| Diastolic dysfunction |
| NO |
108(22%) |
546(29.3%) |
ns |
| Mild |
90(18.3%) |
228(12.2%) |
|
| Moderate |
246(50%) |
286(46%) |
|
| Severe |
68(13.82%) |
234(12.5%) |
|
| More than two vessels |
460(93.5%) |
1698(91%) |
ns |
| LM Disease |
108(21.2%) |
300(16.1%) |
ns |
|
